Given the connection between monocytic AML and BCL2 inhibitor resistance, we set out to determine if the co-expression of AHR and HLA-E could discriminate BCL2 family expression as well as expression of an immune repertoire. The gene discussed is BCL2; the disease is acute myeloid leukemia.